Harvard Bioscience (HBIO) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -60.91% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -75.56% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -74.28% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 155.18% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -99.91% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -117.38% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 114.19% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 123.74% |
| 10 | Harvard Bioscience | 28.05 Mn | 20.96 Mn | 12.24 Mn | 98.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.45% |
| Dec 31, 2025 | 20,964.69% |
| Sep 30, 2025 | 116.35% |
| Jun 30, 2025 | 60.44% |
| Mar 31, 2025 | -2,436.80% |
| Dec 31, 2024 | 95.26% |
| Sep 30, 2024 | -81.81% |
| Jun 30, 2024 | -434.19% |
| Mar 31, 2024 | -259.99% |
| Dec 31, 2023 | 80.96% |
| Sep 30, 2023 | -93.52% |
| Jun 30, 2023 | -79.36% |
| Mar 31, 2023 | 145.98% |
| Dec 31, 2022 | 63.82% |
| Sep 30, 2022 | -909.84% |
| Jun 30, 2022 | 12,401.05% |
| Mar 31, 2022 | -4,967.63% |
| Dec 31, 2021 | -125.62% |
| Sep 30, 2021 | 28.95% |
| Jun 30, 2021 | -87.16% |